针对当前制药企业新药研发面临的巨大挑战,本文提出企业必须从资源整合上升到能力整合。为此,文章构建了制药企业新药研发能力整合战略,井通过能力整合矩阵,详细讨论各类能力间的相互作用。最后,以日本武田制药为例进行了应用分析。 In response to the huge challenges facing the current pharmaceutical companies in research and development of new drugs, this paper proposes that enterprises must rise from resource integration to capacity integration. To this end, the article builds a pharmaceutical enterprise strategy of integration of research and development capabilities of new drugs, and through the ability to integrate matrix, discusses in detail the interaction between various capabilities. Finally, the application analysis was made in Japan Takeda Pharmaceutical.